Armata Pharmaceuticals, Inc. (ARMP) Operating cash flow 2016–2025
Armata Pharmaceuticals, Inc. (ARMP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.8MFY2025 · since FY2016: -$10.6M → -$25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.8M | +31.4% |
| FY2024 | -$37.6M | +20.8% |
| FY2023 | -$47.4M | -46.0% |
| FY2022 | -$32.5M | -37.8% |
| FY2021 | -$23.6M | -29.0% |
| FY2020 | -$18.3M | -17.3% |
| FY2019 | -$15.6M | -46.6% |
| FY2018 | -$10.6M | -15.6% |
| FY2017 | -$9.2M | +13.3% |
| FY2016 | -$10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice